1,2:5,6-Bis-o-(1-methylethylidene)-D-mannitol, 95.0%, 10g

19-Norethindrone acetate, 95.0%, 5g

N-Boc-5-Bromoanthranilic acid, 95.0%, 1g

3-Chloro-6-ethyl-benzo[b]thiophene-2-carboxylic acid hydrazide, 95.0%, 1g

Ester NHS de l’acide 6-azidohexanoïque 500 mg

4-[2-(3-Bromophenoxy)ethyl]morpholine, 97.0%, 5g

(R)-2-(2-(DIPHENYLPHOSPHINO)PHENYL)-4,5-DIHYDRO-4-PHENYLOXAZOLE, 98%, 5g

1-Hydroxycyclohexanecarbonitrile, 97%, 100mg

3-(3-Fluoropyridin-4-yl)propanoic acid, 98%, 250mg

2-Acetamido-4,6-O-benzylidene-2-deoxy-beta-D-glucopyranosyl Azide>98.0%(HPLC)5g

4-Hydroxymethyl-2-methoxyphenylboronic acid, 95+%, 1g

tert-Butyl 1-(hydroxymethyl)-2-azabicyclo[2.1.1]hexane-2-carboxylate, 98%, 500mg

Flacons à fond rond à double col et col latéral parallèle, 1000 ml, 14/23, 1 pièce